Remarkably, analysis of cirrhotic livers from patients followed up during a span of 10 years38 showed that high PARP14 expression positively correlated with a progression of cirrhosis to HCC and reduced survival rate, suggesting that PARP14 expression levels could be a new biomarker for the risk of HCC. This evidence concerns the gene PARP14 and hepatocellular carcinoma.